» Articles » PMID: 16616013

Time Course of Microvascular Resistance of the Infarct and Noninfarct Coronary Artery Following an Anterior Wall Acute Myocardial Infarction

Overview
Journal Am J Cardiol
Date 2006 Apr 18
PMID 16616013
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have suggested that coronary flow velocity reserve (CFVR) in the early phase of acute myocardial infarction (AMI) is abnormal in infarcted and remote regions. This study determined the coronary microvascular resistance of infarct-related arteries (IRAs) and non-IRAs during AMI and at follow-up in patients who were treated with primary percutaneous intervention. In 73 patients with a first anterior wall AMI, baseline and minimal microvascular resistance in IRAs and non-IRAs immediately after reperfusion and at 1-week and 6-month follow-up were calculated as the ratio of mean transvascular pressure gradient to mean baseline and to adenosine-induced hyperemic blood flow velocity, respectively. CFVR in IRAs increased from 1.6 +/- 0.4 after reperfusion to 1.9 +/- 0.5 at 1 week and to 3.0 +/- 0.8 at 6 months (p <0.0001) and in non-IRAs from 2.4 +/- 0.5 to 2.7 +/- 0.6 at 1 week to 3.3 +/- 0.6 at 6 months (p <0.0001). Minimal microvascular resistance in IRAs and non-IRAs (3.2 +/- 1.7 and 2.2 +/- 0.6 mm Hg/second/cm, respectively) decreased significantly at follow-up (2.0 +/- 0.6 and 1.7 +/- 0.6 mm Hg/second/cm at 1 week and 1.8 +/- 0.6 and 1.8 +/- 0.7 mm Hg/second/cm at 6 months, respectively). After correction for rate-pressure product, baseline microvascular resistance after reperfusion and at 6 months did not significantly differ between IRAs and non-IRAs. In conclusion, minimal microvascular resistance is higher in infarcted and noninfarcted regions during AMI than at follow-up. The low CFVR in remote regions during AMI is probably due more to disturbed autoregulation than to increased myocardial workload.

Citing Articles

Predictors of diastolic deceleration time of coronary flow velocity of infarct related and reference coronary artery assessed by transthoracic Doppler echocardiography in the chronic phase of successfully reperfused anterior myocardial infarction:....

Giga V, Tesic M, Beleslin B, Boskovic N, Sobic-Saranovic D, Jovanovic I Front Cardiovasc Med. 2023; 10:1196206.

PMID: 37771666 PMC: 10523777. DOI: 10.3389/fcvm.2023.1196206.


Coronary Microcirculation: The Next Frontier in the Management of STEMI.

Milasinovic D, Nedeljkovic O, Maksimovic R, Sobic-Saranovic D, Dukic D, Zobenica V J Clin Med. 2023; 12(4).

PMID: 36836137 PMC: 9962942. DOI: 10.3390/jcm12041602.


One-year results from the Assessing MICRO-vascular resistances IMR to predict outcome in ST-elevation myocardial infarction patients with multivessel disease undergoing primary PCI (AMICRO) trial.

Fineschi M, Verna E, Barioli A, Mezzapelle G, Bartolini D, Turiano G Front Cardiovasc Med. 2022; 9:1051174.

PMID: 36531736 PMC: 9755670. DOI: 10.3389/fcvm.2022.1051174.


Microcirculation function assessment in acute myocardial infarction: A systematic review of microcirculatory resistance indices.

Silva M, Paiva L, Teixeira R, Ferreira M, Goncalves L Front Cardiovasc Med. 2022; 9:1041444.

PMID: 36440005 PMC: 9691675. DOI: 10.3389/fcvm.2022.1041444.


Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease.

Di Serafino L, Magliulo F, Esposito G Interv Cardiol. 2021; 16:e24.

PMID: 34400971 PMC: 8353546. DOI: 10.15420/icr.2020.28.